Drug
Krp 203
Krp 203: highest development phase Phase 1, developed by Priothera SAS. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Priothera SAS
Trials
| Drug | Phase | Indication |
|---|---|---|
| KRP-203 NCT07937046 | Phase 1 |
Latest
No recent events.
Follow Krp 203 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.